Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation

British Journal of Pharmacology

Volumn 132, Issue 8, 2001, Pages 1777-1788

  Vacaresse, Nathalie ^a   Vieira, Otília ^a,b   Robbesyn, Fanny ^a   Jürgens, Günther ^c   Salvayre, Robert ^a   Negre Salvayre, Anne ^a  

^a INSERM   (France)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

4 Hydroxynonenal; Antioxidants; Atherosclerosis; Caffeic acid; EGF receptor; Oxidized LDL; Trolox; Tyrosine phosphorylation

Indexed keywords

4 HYDROXYNONENAL; A 1478; A 25; A 46; ALPHA TOCOPHEROL; ANTIOXIDANT; CAFFEIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN TYROSINE PHOSPHATASE; TROLOX C; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; AUTOPHOSPHORYLATION; BLOOD VESSEL WALL; CONTROLLED STUDY; DEPHOSPHORYLATION; DERIVATIZATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035031190     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703981     Document Type: Article

References (48)

1. The sphingomyelinceramide signaling pathway is involved in oxidized LDL-induced cell proliferation
2. Alpha-tocopherol as a modulator of smooth muscle cell proliferation
3. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation
4. The role of oxidized lipoproteins in atherogenesis
5. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
6. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition
7. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms
8. Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells
9. Antioxidants and atherosclerotic heart disease
10. Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells
11. Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase
12. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
13. Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
14. Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions
15. Antioxidants and coronary artery disease
16. Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor
17. The low-density lipoprotein pathway and its relation to atherosclerosis
18. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
19. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs
20. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low-density lipoprotein hypothesis
21. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
22. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a)
23. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents
24. Mitochondrial H2O2 formation: Relationship with energy conservation
25. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury
26. Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein
27. Multiple positive and negative regulators of signaling by the EGF-receptor
28. Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways
29. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
30. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: A possible role in cell proliferation and atherogenesis
31. Antioxidants in the prevention of atherosclerosis
32. Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL
33. Redox signaling: Hydrogen peroxide as intracellular messenger
34. Specificity within the EGF family/ErbB receptor family signaling network
35. The pathogenesis of atherosclerosis: A perspective for the 1990s
36. Prevention by alpha-tocopherol and rutin of glutathione and ATP depletion induced by oxidized LDL in cultured endothelial cells
37. Measurement of protein using bicinchoninic acid
38. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions
39. Role of oxidatively modified LDL in atherosclerosis
40. Activation of EGF receptor by oxidized LDL
41. Lethal damage to endothelial cells by oxidized low density lipoprotein: Role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions
42. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: Potential role in oxidized LDL-induced apoptosis
43. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL
44. Stearate inhibition of breast cancer cell proliferation. A mechanism involving epidermal growth factor receptor and G-proteins
45. Role of oxidized low density lipoprotein in atherogenesis
46. Ferrous ion oxidation in the presence of ferric ion indicator xylenol orange for measurement of hydroperoxides
47. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors
48. Lipid peroxides and human diseases